生物活性成分市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

全球生物活性成分市場預計將從 2025 年的 1,751.1 億美元大幅成長至 2031 年的 2,838.1 億美元，複合年成長率為 8.38%。

這些成分，包括益生菌、 Omega-3脂肪酸和植物化學物質等天然來源物質，不僅提供基本的營養，還能產生調節代謝過程的生物效應。推動這一成長趨勢的關鍵因素包括全球文明病的增加以及消費者行為向預防性醫療保健策略的顯著轉變。此外，隨著世界人口老化，對營養干預的需求持續成長，從而推動了對添加了這些健康促進成分的營養補充劑和機能性食品的持續需求。

儘管存在這些積極因素，但由於有關健康益處聲明的法規結構嚴格且不一致，該行業仍面臨許多挑戰。這往往導致合規成本高昂和產品上市延遲。這些法規的複雜性要求產品在進入各個國際市場之前，必須經過廣泛的科學檢驗以證明其有效性。全球EPA和DHA Omega-3組織（GO-EPA）強調了該領域關鍵細分市場的經濟重要性，並報告稱，到2024年，全球EPA和DHA Omega-3原料市場規模將達到23.8億美元。

市場促進因素

消費者對機能性食品和飲料日益成長的需求正在改變生物活性成分產業，而這種需求的驅動力源自於消費行為的根本性轉變——從被動治療轉向主動健康管理。人們越來越重視飲食，將其作為維持健康的主要手段，並積極尋求富含抗氧化劑、胜肽和益生菌的產品，以解決免疫力和消化系統健康等特定問題。這種行為轉變迫使製造商從生產標準食品轉向生產高價值功能性產品，從而推動了對經科學驗證的化合物的需求。根據Granvia Nutritional發布的2024年1月零食消費趨勢分析報告，全球61%的消費者持續選擇健康零食，顯示功能性營養正成為主流。

同時，消費者對天然和植物性成分日益成長的偏好是市場成長的關鍵驅動力，迫使供應商不斷改進植物萃取技術和潔淨標示解決方案。在消費者對合成添加劑的批評日益增多的背景下，各大品牌正以植物來源的生物活性物質取代人工成分，從而確保標籤透明並符合道德標準。這一趨勢促使消費者普遍傾向於選擇被認為本質上安全的成分，植物性食品協會 (PBFA) 2024 年 5 月的報告也印證了這一點，該報告估計美國植物來源食品零售市場規模為 81 億美元。此外，國際食品資訊理事會 (IFIC) 2024 年 6 月的調查報告顯示，71% 的美國人計劃增加蛋白質攝取量，這反映出人們對營養的日益關注正在推動該行業的發展。

市場挑戰

圍繞著健康聲明的嚴格且不一致的監管體系，對全球生物活性成分市場的成長構成重大障礙。製造商身處複雜的市場環境，不同地區的核准標準差異顯著，同一成分在不同地區往往需要進行多項高成本的科學測試才能獲得認證。這種缺乏統一性的做法，大幅增加了遵循成本，延緩了創新功能性成分的商業化進程，並使企業對那些以核准程序嚴格或不明確著稱的市場望而卻步。因此，這些高昂的財務壁壘限制了競爭，並延緩了新型生物活性解決方案的推出。

這些監管挑戰限制了已在特定區域市場取得成功的產品的國際分銷，直接削弱了市場潛力。該行業龐大的規模凸顯了這些貿易管道障礙造成的機會損失。例如，根據美國植物委員會 (ABC) 預測，2024 年美國草藥膳食補充劑的零售額將達到創紀錄的 132.3 億美元，凸顯了巨大的消費者需求。然而，缺乏統一的全球標準嚴重限制了這些高需求品類的跨國擴張，從而阻礙了整個產業的收入成長。

市場趨勢

將精準發酵技術應用於非動物性生物活性物質的生產，正在重塑供應鏈，實現膠原蛋白、乳鐵蛋白和人乳低聚醣等複雜化合物的規模化生產，而這些化合物先前均來自動物。該技術能夠設計微生物並合成相同的生物活性分子，有效將生產與畜牧業脫鉤，同時應對緊迫的永續性和供應鏈穩定性挑戰。這項轉型吸引了大量資金用於加強基礎建設和商業化進程，凸顯了該產業的永續發展潛力。正如良好食品研究所（Good Food Institute）在2025年6月指出的那樣，2024年全球發酵公司獲得了6.51億美元的私人融資，用於推動這些先進生產平台的發展。

同時，人工智慧在成分發現領域的應用正在革新研發模式，使其從傳統的試驗誤法轉向預測性、數據驅動的策略。透過利用機器學習演算法，科學家可以快速分析龐大的植物性因組資料庫，識別出具有顯著健康益處的特定植物化學物質和胜肽類，這些物質先前要么無法檢測到，要么提取成本過高。這種技術協同作用顯著縮短了研發週期，並揭示出能夠滿足特定健康需求（例如代謝支持和肌肉恢復）的強效生物活性物質。作為該領域投資的典型例證，Nuritas公司於2024年12月宣布已籌集4,200萬美元，用於擴展其人工智慧驅動的平台，該平台專注於智慧發現天然存在的生物活性成分。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球生物活性成分市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品成分（膳食纖維、維生素、 Omega-3多元不飽和脂肪酸、植物萃取物、礦物質、類胡蘿蔔素/抗氧化劑、益生菌、其他）
  • 按應用領域（功能性食品和飲料、營養補充品、臨床營養、個人護理、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美生物活性成分市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲生物活性成分市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區生物活性成分市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲生物活性成分市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲生物活性成分市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球生物活性成分市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Sabinsa Corporation
• Archer Daniels Midland Company（ADM）
• BASF SE
• Cargill Inc.
• Ingredion Inc.
• Ajinomoto Co., Inc.
• Owen Biosciences Inc.
• Nuritas Ltd.
• DuPont de Nemours, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Bioactive Ingredients Market is projected to expand significantly, rising from USD 175.11 Billion in 2025 to USD 283.81 Billion by 2031, reflecting a CAGR of 8.38%. These ingredients, which include naturally occurring substances like probiotics, omega-3 fatty acids, and phytochemicals, offer biological benefits that extend beyond basic nutrition to modulate metabolic processes. Key factors driving this trajectory include the rising global incidence of chronic lifestyle-related diseases and a marked consumer pivot toward preventative health strategies. Furthermore, an aging global demographic is fueling a consistent need for nutritional interventions, thereby sustaining demand for nutraceuticals and functional foods enhanced with these health-promoting components.

Despite these positive indicators, the industry encounters substantial obstacles due to rigorous and inconsistent regulatory frameworks regarding health claims, which often inflate compliance costs and postpone product launches. This regulatory complexity necessitates extensive scientific validation to prove efficacy before products can be introduced into various international markets. Highlighting the economic significance of major segments within this domain, the Global Organization for EPA and DHA Omega-3s reported that the global market for EPA and DHA omega-3 ingredients reached a value of US$2.38 billion in 2024.

Market Driver

The escalating appetite for functional foods and beverages is transforming the bioactive ingredients sector, propelled by a fundamental consumer shift from reactive treatments to proactive wellness management. Individuals are increasingly utilizing diet as a primary tool for health maintenance, actively seeking products enriched with antioxidants, peptides, and probiotics to target specific issues like immunity and digestive health. This behavioral change compels manufacturers to upgrade standard grocery offerings into value-added functional goods, thereby boosting the demand for scientifically backed compounds. According to Glanbia Nutritionals' January 2024 analysis of snacking trends, 61% of global consumers consistently look for healthier snack options, demonstrating the mainstream adoption of functional nutrition.

Concurrently, the rising inclination toward natural and plant-based ingredients serves as a vital engine for market growth, urging suppliers to advance botanical extraction technologies and clean-label solutions. As consumers become more critical of synthetic additives, brands are substituting artificial elements with plant-derived bioactives to ensure label transparency and align with ethical standards. This trend influences a wide demographic to favor ingredients viewed as inherently safer, as evidenced by the Plant Based Foods Association's May 2024 report, which valued the U.S. plant-based food retail market at US$8.1 billion. Furthermore, the International Food Information Council's June 2024 survey noted that 71% of Americans are striving to increase their protein intake, reflecting the deep nutritional engagement driving this industry.

Market Challenge

Rigorous and disjointed regulatory systems regarding health claims create a significant impediment to the progress of the Global Bioactive Ingredients Market. Manufacturers navigate a convoluted landscape where approval criteria differ widely by region, necessitating multiple costly scientific trials to validate the same ingredient for various territories. This absence of harmonization drastically elevates compliance expenses and retards the commercialization of innovative functional ingredients, frequently deterring companies from engaging with markets known for strict or unclear approval procedures. Consequently, these high financial barriers restrict competition and decelerate the introduction of new bioactive solutions.

These regulatory challenges directly curtail market potential by restricting the international distribution of products that have already achieved success in specific local markets. The magnitude of the sector highlights the opportunities lost due to these obstructed trade avenues. For instance, the American Botanical Council reported that retail sales of herbal dietary supplements in the United States hit a record US$13.23 billion in 2024, illustrating immense consumer demand. However, the lack of unified global standards severely limits the ability of such high-demand categories to scale seamlessly across borders, thereby suppressing the overall revenue growth of the industry.

Market Trends

The integration of precision fermentation for animal-free bioactives is reshaping the supply chain by facilitating the scalable creation of complex compounds, such as collagen, lactoferrin, and human milk oligosaccharides, which were traditionally sourced from animals. This technology permits the engineering of microorganisms to synthesize identical bioactive molecules, effectively decoupling production from livestock farming while addressing urgent sustainability and supply stability issues. This transition is drawing significant capital to bolster infrastructure and commercialization efforts, confirming the sector's enduring potential. As noted by the Good Food Institute in June 2025, fermentation companies globally secured US$651 million in private funding during 2024 to further these advanced production platforms.

In parallel, the application of artificial intelligence in ingredient discovery is revolutionizing research and development, moving it from traditional trial-and-error methods to predictive, data-centric strategies. By utilizing machine learning algorithms, scientists can rapidly analyze extensive plant genomic databases to pinpoint specific phytochemicals and peptides with significant health advantages that were previously undetected or too expensive to extract. This technological synergy drastically reduces development schedules and reveals potent bioactives for specific health needs, such as metabolic support and muscle recovery. Highlighting the investment in this area, Nuritas announced in December 2024 that it had raised US$42 million to broaden its AI-driven platform focused on uncovering intelligent nature-based bioactive ingredients.

Key Market Players

• Sabinsa Corporation
• Archer Daniels Midland Company (ADM)
• BASF SE
• Cargill Inc.
• Ingredion Inc.
• Ajinomoto Co., Inc.
• Owen Biosciences Inc.
• Nuritas Ltd.
• DuPont de Nemours, Inc.

Report Scope

In this report, the Global Bioactive Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioactive Ingredients Market, By Product

• Fiber
• Vitamins
• Omega 3 PUFA
• Plant Extracts
• Minerals
• Carotenoids & Antioxidants
• Probiotics
• Others

Bioactive Ingredients Market, By Application

• Functional Food & Beverage
• Dietary Supplements
• Clinical Nutrition
• Personal Care
• Others

Bioactive Ingredients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioactive Ingredients Market.

Available Customizations:

Global Bioactive Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioactive Ingredients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Fiber, Vitamins, Omega 3 PUFA, Plant Extracts, Minerals, Carotenoids & Antioxidants, Probiotics, Others)
  • 5.2.2. By Application (Functional Food & Beverage, Dietary Supplements, Clinical Nutrition, Personal Care, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Bioactive Ingredients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioactive Ingredients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Bioactive Ingredients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Bioactive Ingredients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Bioactive Ingredients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bioactive Ingredients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Bioactive Ingredients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Bioactive Ingredients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Bioactive Ingredients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Bioactive Ingredients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Bioactive Ingredients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bioactive Ingredients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Bioactive Ingredients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Bioactive Ingredients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Bioactive Ingredients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Bioactive Ingredients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Bioactive Ingredients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bioactive Ingredients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Bioactive Ingredients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Bioactive Ingredients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Bioactive Ingredients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bioactive Ingredients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Bioactive Ingredients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Bioactive Ingredients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bioactive Ingredients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sabinsa Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Archer Daniels Midland Company (ADM)
• 15.3. BASF SE
• 15.4. Cargill Inc.
• 15.5. Ingredion Inc.
• 15.6. Ajinomoto Co., Inc.
• 15.7. Owen Biosciences Inc.
• 15.8. Nuritas Ltd.
• 15.9. DuPont de Nemours, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer